EVALUATION OF PREGNANCY ASSOCIATED HYPERTENSIVE STATES
https://doi.org/10.15829/1560-4071-2014-5-97-100
Abstract
Aim. The main aim of current study was to investigate the significance and prevalence of the different risk factors for hypertension, caused by pregnancy. Material and methods. We evaluated different risk factors in 120 pregnant women with hypertensive states (main group) and in 50 healthy pregnant women at the same gestation period (control group). In pregnant women we evaluated the absence either presence of of pre-eclampsy risk factors: age, parity, hypertensive disorders during previous pregnancies, time gone since previous pregnancy, obesity, hypertension family anamnesis, inferlility, multiple precnancy, extragenital diseases. To calculate the relations between different qualitative signs the Pirson х used. Results. During the study it was revealed that in hypertension disorders the women had one risk factor in 30 (35,5%), two risk factors in 29 (34,1%), three and more risk factors in 26 (30,6%). It was found that in 30% of pregnants with pre-eclampsy and gestational hypertension there are no any risk factors. Most significant risk factors were first pregnancy and extragenital pathology. Combination of three and more risk factors is an anamnestic marker for higher risk of severe pre-eclampsy.
Conclusion. The analysis of hypertension risk factors in pregnant women makes evidence-based the recognition of the high-risk group for pre-eclampsy. Further detailed diagnostic investigation of these women provides the opportunity to start a prophylaxy of hypertension disorders in pregnancy and to monitor the condition of clotting system, fetus condition and to improve the outcomes of a pregnancy. Absence of the risk factors does not decline a possibility of pre-eclampsy and requires the search for additional markers that would be early and pathogenetically proven signs.
References
1. Royal College of Obstetricians and Gynaecologists. THE MANAGEMENT OF SEVERE PREECLAMPSIYA/ECLAMP-SIYA. Guideline 10, RCOG Press, March 2006.
2. Ounningham FG, Leveno KJ, Bloom SL, et al. Hypertensive disorders in pregnancy. 22 ed. New York, 2005: 761-808.
3. The Society of Obstetricians and Gynaecologists of Canada. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy. Journal of Obstetrics and Gynaecology Canada 2008; Volume 30, Number 3, Supplement 1, March.
4. Facchinetti F, Marozio L, Frusca T, et al. Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol. 2009 Jan; 200 (1): 46.e1-5. Epub 2008 Oct 9.
5. Romundstad PR, Magnussen EB, Smith GD, et al. Hypertension in pregnancy and later cardiovascular risk: common antecedents? J Circulation. 2010; Aug 3; 122 (5): 478-87.
6. Magnussek EB. Prepregnancy cardiovascular risk as predictors of preeclampsia: population based cohort study. BMJ. 2007; 335: 978-86.
7. Vikse BE, Hallan S, Bostad L, et al. Previous preeclampsia and risk for progression of
8. biopsy-verified kidney disease to end-stage renal disease. J Nephrol Dial Transplant. 2010; Oct; 25 (10): 3289-96.
9. Bussen S. Influence of the vascular endothelial growth, factor on the development of severe pre-eclampsia or HELLP syndrome. Arch. Gynecol Obstet. 2010; Oct 13: 24-32.
10. Drost JT, Maas AH, van Eyck J, et al. Preeclampsia as a female-specific risk factor for chronic hypertension. J. Circulation. 20104 Aug 10; 122 (6): 579-584.
11. Hertig A, Liere P. New markers in preeclampsia. Clin. Chim. Acta. 2010; Nov 11; 411 (21-22): 1591-5.
12. Lorquet S, Pequeux C, Munaut C, et al. Aetiology and physiopathology of pre-eclampsia and related forms. J Acta Clin. Belg. 2010; Jul-Aug; 65 (4): 237-241.
13. Mao D, Che J, Li K, et al. Association of homocysteine, asymmetric dimethylargi-nine, and nitric oxide with preeclampsia. Arch. Gynecol. Obstet. 2010; Oct; 282 (4): 371-5.
14. Duckitt K. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; Mar. 12; 330:565.
Review
For citations:
Shakhbasova N.A. EVALUATION OF PREGNANCY ASSOCIATED HYPERTENSIVE STATES. Russian Journal of Cardiology. 2014;(5):97-100. (In Russ.) https://doi.org/10.15829/1560-4071-2014-5-97-100